Find a clinical trial
Parkinson Disease
Compassionate Use Study of Pergolide in Patients With Parkinson's Disease
This compassionate use study is designed to monitor safety in patients who have been doing well on pergolide therapy, wish to continue treatment, and have not been able to tolerate alternative treatments.
- Trial name
- NCT00624741
- Testing
- Pergolide
- Sponsor
- Bausch Health Americas, Inc.
Osteoarthritis of the Hand
Compassionate Use of Pennsaid Topical Lotion (Diclofenac) in Osteo or Rheumatoid Arthritis
This was a compassionate use, open treatment safety study of Pennsaid topical lotion (diclofenac) for osteo or rheumatoid arthritis.
- Trial name
- NCT01579890
- Testing
- Diclofenac
- Sponsor
- Mallinckrodt
Heart Failure, Cardiomyopathies
Assess Safety and Probable Benefit of the EXCOR® Pediatric Ventricular Assist Device Under a Continued Access Protocol
The main purpose of this protocol is to provide a mechanism for continued access for patients that would have been enrolled into the primary cohorts of the IDE study.
- Trial name
- CAP (NCT01242891)
- Testing
- EXCOR® Pediatric Ventricular Assist Device
- Sponsor
- Berlin Heart, Inc
Iron Overload
Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
Patients who have iron overload due to chronic blood transfusions and have developed heart failure or who are at high risk of heart failure because of the high levels of iron in their hearts, will be treated with deferiprone, an…
- Trial name
- NCT00293098
- Testing
- deferiprone
- Where
- United States
- Sponsor
- Children's Hospital of Philadelphia
Cystic Fibrosis
VX-770 Expanded Access Program
The purpose of this expanded access program is to provide VX-770 prior to its commercial availability to people with cystic fibrosis (CF) who have at least one copy of the G551D-CFTR mutation and who are in critical medical need…
- Trial name
- NCT01381289
- Testing
- VX-770
- Sponsor
- Vertex Pharmaceuticals Incorporated
Cystic Fibrosis, Pseudomonas Aeruginosa Airway Infection
Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection
The primary objective of this program is to provide expanded access to aztreonam lysine for inhalation (AZLI) 75 mg prior to its commercial availability to patients with cystic fibrosis (CF) and chronic P.
- Trial name
- NCT00499720
- Testing
- Aztreonam Lysine for Inhalation
- Where
- 65 sites in United States, Puerto Rico
- Sponsor
- Gilead Sciences
HIV Infections
Atazanavir for HIV Infected Individuals: An Early Access Program
The purpose of this clinical research study is to provide atazanavir to patients infected with human immunodeficiency virus (HIV) whose antiviral medications are no longer working to control HIV activity within the body and who…
- Trial name
- NCT00046345
- Testing
- Atazanavir (BMS-232632)
- Where
- 165 sites in United States, Puerto Rico
- Sponsor
- Bristol-Myers Squibb
Cutaneous Leishmaniasis
Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis
Current standard therapies with chemotherapy (CT) for Cutaneous Leishmaniasis (CL) are expensive, toxic/allergenic, frequently ineffective, burdensome, and often unavailable.
- Trial name
- HECT (NCT01277796)
- Testing
- Heat pack conduction-heat therapy
- Sponsor
- Universidad Peruana Cayetano Heredia
Parkinson's Disease
Development of a Fall Prevention and Fall Detection System for Ambulatory Rehabilitation of Parkinson's Patients
The investigators plan to conduct a first-stage experiment by recruiting ten subjects, including five PD patients and five non-PD patients.
- Trial name
- NCT01262950
- Testing
- portable motion detector
- Sponsor
- Far Eastern Memorial Hospital
Infection, Precancerous/Nonmalignant Condition
Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection
RATIONALE: Collecting the T cells from a donor and transplanting them into a patient may be effective treatment for immunodeficiency syndrome and CMV infection.
- Trial name
- NCT00547235
- Testing
- therapeutic allogeneic lymphocytes, allogeneic bone marrow transplantation, total-body irradiation
- Where
- United States
- Sponsor
- Fred Hutchinson Cancer Center
Neuroblastoma
Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma
GE Healthcare has recently submitted a New Drug Application (NDA) for Iobenguane I 123 Injection ([123I]mIBG (AdreView)) as a diagnostic nuclear imaging agent for the detection of primary or metastatic neuroblastoma and…
- Trial name
- NCT00730444
- Testing
- Iobenguane I 123 Injection
- Where
- United States
- Sponsor
- GE Healthcare
Phenylketonuria
Sapropterin Expanded Access Program
The Purpose of this study is to provide patients with hyperphenylalaninemia (HPA) due to Phenylketonuria (PKU) access to sapropterin dihydrochloride and to collect more information about the safety of the drug in an expanded…
- Trial name
- NCT00484991
- Testing
- Sapropterin dihydrochloride
- Where
- 36 sites in United States
- Sponsor
- BioMarin Pharmaceutical
Multiple Myeloma
A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE
The purpose of this study is to give patients who have had 4 or more prior lines of therapy for multiple myeloma access to VELCADE.
- Trial name
- NCT00063791
- Testing
- Bortezomib
- Where
- 3 sites in United States
- Sponsor
- Millennium Pharmaceuticals, Inc.